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ABSTRACT   
   The burden of cancer, leading cause of death in 
developed countries, is increasing due to population aging 
and growth. In the general population there are higher 
mortality rates in winter than in summer. This study 
investigates seasonal changes in cancer mortalities (lung 
and breast cancer) in the Dutch population (1996-2016) 
and whether mortality in winter is correlated more with 
average temperatures, or more with influenza incidence. 
Results showed that temperature changes and higher 
influenza incidence in winter are associated with higher 
mortality rates. This was not seen in patients with lung and 
breast cancer, but it is important to address. 
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INTRODUCTION 
   Cancer, the leading cause of death in economically 
developed countries, has an increasing burden because of 
population aging and growth, as well as of various cancer-
associated lifestyles (smoking, physical inactivity, 
“westernized” diet, etc.) [1]. Cancer incidence is 
determined by exposure to etiologic factors and by 
individual susceptibility, and may also be affected by 
earlier and better diagnosis. Cancer mortality is influenced 
by cancer incidence, genetic makeup, tumor 
characteristics, stage at diagnosis, and response to 
available treatment [2]. In the Netherlands, 45 790 people 
died from cancer in 2016, and this number has 
dramatically risen from 1996 to 2016 (increase of 16.4%) 
[3]. Cancer of the lung, stomach, colon, liver, and 
esophagus have been associated with the highest incidence 
worldwide, in addition to sex-specific malignancies of the 
female breast, uterine cervix, and male prostate [2].                                                                          
   It has been observed that in the general population there 
is a higher mortality rate in winter than in summer, 
possibly due to the characteristics of the weather. For 
example, a Finnish study reported that all major stroke 
subtypes occurred more frequently in autumn [4]. In 
addition, a Serbian study concluded that seasonal 
variations were most pronounced in mortality from 
cardiovascular and respiratory diseases, with the highest 
mortality rates recorded in February and March [5]. 
Furthermore, a Hungarian study showed that majority of 
deaths from cancers of female genital organs occurred in 
winter, and a significant seasonal pattern was revealed for 
deaths from breast cancer with a peak in January [6].  
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  Severe infections have been associated with prolonged 
hospitalization and treatment delay, and are a major cause 
of mortality [7]. Infections in cancer patients can result from 
immunosuppression due to the treatment, or due to the 
malignancy itself. In contrast to hematological cancers, such 
as leukemia, breast cancers are not essentially linked to an 
immune deficit. Yet, limited data is available on the 
incidence of serious infections in cancer patients. One 
Swedish study assessed the risk and implications of serious 
infections in breast cancer patients by using registry-based 
data. In total, 720 breast cancer patients experienced an 
infection-related hospitalization during a median follow-up 
of 4.9 years [8]. Infections acquired by respiratory viruses, 
such as influenza, thus far have received little attention 
regarding cancer mortalities. Influenza viruses, due to their 
genotypic plasticity, cause yearly epidemics which result in 
significant clinical impacts [9].  
   In the Netherlands, lung cancer and breast cancer are two 
most prevalent cancer types, with a prevalence of 25 204 
and 132 275 respectively in 2016 [10]. Despite therapeutic 
advances, little gain has been achieved in overall lung 
cancer survival over the past 30 years, with approximately 
15% five-year survival rates for all stages [11]. The greatest 
risk factor for developing female breast cancer is aging. 
However, while incidence rates for most epithelial cancers 
rise steadily with aging, rates for female breast cancer 
increase rapidly until approximately age 50, and then rise 
more slowly.   
   The main purpose of this research is to investigate 
seasonal changes in cancer mortalities, specifically 
lung/trachea cancer and female breast cancer mortalities, in 
the Dutch population from 1996 to 2015. These results will 
be compared with the seasonal changes in mortality rates 
from the most common cardiovascular diseases. The 
hypothesis is that cancer mortality and cardiovascular 
disease mortality will be increased during the first and the 
fourth quarters of the years (which include the winter 
seasons). Furthermore, the goal will be to investigate 
whether mortality in the winter season is correlated more 
with the average temperatures, or more with the seasonal 
influenza incidence. 
 
MATERIALS AND METHODS 
Study population 
   Data was obtained from the open electronic database of the   
Central Bureau of Statistics (CBS) of the Netherlands [3]. The 
number of deaths from cancers and cardiovascular diseases 
were available from 1996 and were categorized in quarters of 
the year. The last quarter included was the third quarter of 
2016. Both males and females were included in the analysis, 
as well as all age groups. 
   Average monthly temperature figures and the Hellmann 
Index were obtained from the Meteorological Institute of the 
Netherlands [12]. The Hellman index is a measure of the cold 
days during the period from November 1st of the previous 
year, to March 31st of a given year (thus in this research the 
number represented the cold days in the 1st and the 4th 
quarter of the years).  
   Data on influenza incidence was obtained from the 
European Center for Disease Prevention and Control 
(Influenza activity data in the Netherlands) [13]. Data was 
available only from the first quarter of 2009 until the third 
quarter of 2015. 
 
Statistical Methods 
   To examine the seasonal trends occurring in mortality 
cases of lung/trachea cancer, breast cancer, diseases of the 
cardiovascular system, and total causes, line plots were 
constructed using IBM SPSS Software (version 23). For a 
more in-depth analysis, the variable periods was dummy 
coded. A means test was performed for each disease 
category in order to obtain the average difference in 
percentages between deaths in the winter and deaths in the 
summer. 
   Linear regression was performed to investigate the 
relationship between the average temperatures and all 
previously given variables. Also, the Hellmann index was 
analyzed in the same way. Furthermore, to investigate the 
influence of seasonal influenza on cancer mortality, again 
linear regression was performed. The missing data on 
influenza were ruled out, thus only the periods from 2009 
until 2015 were used. 95% confidence intervals were 
calculated and p-values less than or equal to 0.05 were 
considered to be statistically significant. All these analyses 
were performed again using IBM SPSS Software. 
 
RESULTS 
   Overall, there were 197 543, 69 729, 592 643, and 902 065 
deaths from lung/trachea cancer, breast cancer, other 
malignant cancers, and cardiovascular diseases, 
respectively, in the Netherlands during the period 1996–
2016. Most deaths occurred from cardiovascular diseases. 
Among the two major cancer types, most deaths resulted 
from lung/trachea cancer. 
   The average temperature measured during this period was 
M=9.9°C (SD=4.95). The highest average temperature was 
noticed in the third quarter of 2006 (18.6°C), and the lowest 
in the first quarter of 2013 (0.3°C). The average Hellmann 
index was M=45.02 (SD=40.08), meaning that on average, 
the temperatures in the Netherlands were normal during the 
past 20 years.  
 
Investigation of Seasonal Trends  
   Mortality rates from lung/trachea cancer and breast cancer 
showed slight frequencies with positive peaks during the 1st 
and 4th quarters which represent the winter months, and 
negative peaks during the 3rd quarter which represents the 
summer months. Mortality rates from cardiovascular 
diseases and total mortality rates showed stronger 
frequencies, meaning that the correlation between these 
mortality rates and the change in seasons is stronger. 
   Four means tests were performed in order to obtain the 
average differences (in percentages) between the different 
disease categories in the winter and in the summer. The most 
obvious differences occurred within the mortality rates from 
cardiovascular diseases (an increase of 5.4% in the winter). 
The differences within mortality rates from lung/trachea 
cancer (an increase of 0.2% in the summer) and breast 
cancer (an increase of 0.6% in the summer) were not as big. 
 
Investigation of Temperature Changes on Mortality Rates 
   Linear regression was performed to check the association 
between average temperature throughout the period from 
1996-2016 and the mortality rates of the various causes. 
Association was checked between average temperature and 
mortality rates from: lung/trachea cancer, breast cancer, 
cardiovascular diseases, and all causes in total. Statistically 
significant associations were found among average 
temperature and mortality rates from lung/trachea cancer 
(F(1,81)=3.67; p=0.05), among average temperature and 
mortality rates from cardiovascular diseases (F(1,81)=21.51; 
p <0.01), and among average temperature and mortality rates 
from all causes (F(1,81)=132.90; p<0.01). The association 
among average temperature and mortality rates from breast 
cancer was found to be statistically insignificant 
(F(1,81)=0.014; p=0.91). Pearson correlation coefficients 
were calculated for each of the three significant associations. 
The correlation coefficients were negative, meaning that the 
lower the temperature, the higher the number of death cases 
from lung/trachea cancer, cardiovascular diseases and total all 
causes. To further investigate the influence of temperatures 
on mortality rates, the associations between the Hellmann 
index and the four different mortality rate types were 
investigated. However, these results were statistically 
insignificant.  
 
Investigation of Influenza Occurrence on Mortality Rates 
   Linear regression was performed to check for a potential 
association between influenza incidence throughout the 
period from 2009 to 2015, and the mortality rates of the 
various causes. Association was checked for mortality rates 
from lung/trachea cancer, breast cancer, cardiovascular 
diseases, and all causes. Statistically significant results were 
observed for the association between influenza incidence and 
deaths from cardiovascular diseases (F(1,25)=37.71; p<0.01), 
and deaths from all causes (F(1,25)=41,24; p<0.01). The 
associations between influenza incidence and deaths from 
lung/trachea cancer (F(1,25)=0.041; p=0.84) and breast 
cancer (F(1,25)=0.55; p=0.47) were found to be statistically 
insignificant. The Pearson correlation coefficients for the 
statistically significant associations were positive, meaning 
that the higher the incidence of influenza in a certain period, 
the higher the total deaths and the deaths from cardiovascular 
diseases.  
   In order to compare the relationships between total 
mortality rates and both average temperatures and influenza 
incidence, linear regression was performed again for the 
average temperature, this time using the same period as the 
period available for the influenza incidence data (2009-2015), 





Figure 1. Comparison of the relationships between total mortality 
rates and average temperatures (top), and total mortality rates and 




   
   This study had two main goals: (1) to investigate the 
potential relationships between seasonal changes, 
represented by changes in the average temperatures, and the 
changes in mortality rates from the two most common 
cancer types (breast cancer and lung cancer) and from 
cardiovascular diseases, and (2) to examine whether an 
association of influenza incidence with these mortality rates 
exists, and whether it is more or less significant. The results 
showed that a significant difference existed within the 
mortality rates from cardiovascular diseases (an increase of 
5.4% mortality rate in the winter compared to the summer 
periods). A slight negative correlation was also seen within 
mortality rates from lung cancer. The most significant 
difference, however, was seen for total mortality rates; thus 
overall, most of the people died during the winter seasons. 
A significant seasonal pattern was not observed for breast 
cancer mortalities. These results might indicate that breast 
cancer and lung cancer patients mostly die from the burden 
of the cancer itself, rather than due to seasonal effects. The 
main cause of death in such cancers would therefore include 
metastases causing fatal hemorrhages, pulmonary 
thromboembolisms, hepatic failure, and failure of other 
organs [14, 15]. Furthermore, an association with the 
Hellmann index was not seen, indicating that extremely cold 
temperatures during the winter do not have a significant effect 
on mortality rates. 
    
   Significant associations were observed among influenza 
incidence and total mortality rates, and mortality rates from 
cardiovascular diseases. During the years, with a higher 
influenza incidence, more people died. Because influenza 
incidence peaks in the winter seasons, this supports the 
previous results. The associations with influenza were much 
stronger than the associations with the average temperature, 
meaning that, overall, seasonal influenza is likely to have a 
severe impact on mortality rates. 
Limitations of this Study 
 
   The data for this study used to investigate seasonal changes 
was available from 1996-2016, while the data used for 
influenza incidence was only available from 2009-2015. Even 
though the time periods were matched in order to compare the 
two results, this time period was too short to observe any big 
effects of influenza incidence on mortality rates. Future 
research could try replicating this study by using a longer 
timeframe which would lead to much more reliable results. 
   
   This study used mostly linear regression to observe the 
results. A statistical test developed by Stolwijk et al. described 
seasonal patterns as one sine and one cosine function which 
can be incorporated into a regression model [16]. This might 
be a better way to investigate seasonal changes and improve 
the validity of the results. In this case this was not done 
because the IBM SPSS software does not allow manipulation 
of regression analysis outside of its built-in functions. Also, 
SPSS cannot handle longitudinal panel data. 
 
Comparison with Other Studies  
 
   The results of this research are in line with other studies. A 
Norwegian study by Porojnicu et al. investigated the potential 
role of solar exposure on the survival of breast cancer patients. 
They showed that women who are diagnosed during the 
summer had about 25% better survival after standard 
treatment compared with women diagnosed during the winter. 
For women younger than 50 years, the benefit seemed to be 
even higher (40% better survival) [17]. Furthermore, the study 
by Hartai et al. showed a significant seasonality for overall 
deaths, with a peak in January and a large decrease in July [6]. 
 
Hematological Malignancies and Infection 
 
  The main risk factor for developing a serious infection in 
cancer patients is neutropenia. New therapeutic strategies 
have improved the long-term survival of cancer patients in 
recent years, but nevertheless, cytotoxic chemotherapy is the 
key therapeutic option, with neutropenia as its main 
complication. Patients with a hematological malignancy, such 
as leukemia, are especially vulnerable to infections because 
of their suppressed immune system, not only due to treatment, 
but due to the disease itself. Three possible mechanisms have 
been explained to have a role in the immunosuppression of 
leukemia: (1) inhibitory T-cell pathways (especially 
programmed death ligand 1/programmed death 1), (2) 
regulatory immune cells, and (3) metabolic enzymes, such as 
indoeamine-2,3-dioxygenase [18]. 
    
   A study by Marin et al. aimed to identify factors which 
influence mortality in neutropenic patients with 
hematological malignancies. They showed that out of 602 
episodes of bloodstream infections in neutropenic patients, 
510 of them occurred in patients with hematological 
malignancies [19]. On the other hand, infections with influenza 
has not been investigated in this group of patients. The 
outcomes of this study showed that overall mortality is 
greatly correlated with influenza incidence in the winter 
periods. This might indirectly point out that morality rates 
of leukemia patients are greater in the winter months due to 
the higher incidence of influenza. Future research could 




   The main finding of this study suggests that changes in 
temperatures and higher influenza incidences in the winter 
are associated with higher overall mortality rates. Although 
this was not specifically seen in patients with breast and lung 
cancer, it is important to address in the future. Indirectly, the 
study points out that other types of cancers, such as 
leukemia, which are associated with an extensively 
suppressed immune system, might have an increased 
mortality rate in winter seasons due to the incidence of 
influenza. Measures must be taken in order to reduce 
mortality rates associated with seasonal changes 
 
ROLE OF THE STUDENT  
   Magdalena Shumanska was an undergraduate student at 
University College Roosevelt working under the supervision 
of Prof. Ger Rijkers when the research in this report was 
performed. Initially, the project was aimed at investigating 
the influence of seasonal influenza on mortality rates of 
patients suffering from leukemia; however, the data 
regarding this was not available in the open database of the 
CBS. Therefore, this more general project was performed. 
The research question was proposed by the supervisor, and 
the processing of the analysis, results, as well the 
formulation of the discussion, conclusions, and the writing 




   I thank my supervisor, Prof. Ger Rijkers, who helped and 




1.  Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., 
& Forman, D. (2011). Global cancer statistics. CA: A 
Cancer Journal for Clinicians, 61(2), 69-90. 
2.  Kamangar, F., Dores, G. M., & Anderson, W. F. (2006). 
Patterns of cancer incidence, mortality, and prevalence 
across five continents: defining priorities to reduce cancer 
disparities in different geographic regions of the world. 
Journal of Clinical Oncology, 24(14), 2137-2150. 
3. Central Bureau of Statistics, the Netherlands (http:// 
statline.cbs.nl/statweb/). 
4.  Sipilä, J. O., Ruuskanen, J. O., Kauko, T., Rautava, P., 
& Kytö, V. (2016). Seasonality of stroke in Finland. 
Annals of Medicine, 49(4), 1-9. 
5.  Stojic, S., Stanišic, N., Stojic, A., & Džamic, V. (2016). 
Seasonal mortality variations of cardiovascular, 
respiratory and malignant diseases in the city of Belgrade. 
Stanovnistvo, 54(1), 83-104. 
6.  Hartai, M., Nyári, T. A., & McNally, R. J. (2015). Trends 
in mortality rates in female genital organs and breast cancers 
in Hungary between 1979 and 2013. European Journal of 
Obstetrics & Gynecology and Reproductive Biology, 194, 
168-172. 
7. Cooksley, C. D., Avritscher, E. B., Rolston, K. V., & 
Elting, L. S. (2009). Hospitalizations for infection in cancer 
patients: impact of an aging population. Supportive Care in 
Cancer, 17(5), 547-554. 
8.  Brand, J. S., Colzani, E., Johansson, A. L., Giesecke, J., 
Clements, M., Bergh, J., ... & Czene, K. (2016). Infection-
related hospitalizations in breast cancer patients: Risk and 
impact on prognosis. Journal of Infection, 72(6), 650-658. 
9. Reed, C., Chaves, S. S., Kirley, P. D., Emerson, R., 
Aragon, D., Hancock, E. B., ... & Laidler, M. R. (2015). 
Estimating influenza disease burden from population-based 
surveillance data in the United States. PloS one, 10(3), 118-
369. 
10. Dutch Cancer Figures. (n.d.). Retrieved from: http:// 
www.cijfersoverkanker.nl/home-36.html. 
11.  Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. 
L., Ward, E., Ries, L. A., ... & Friedman, C. (2005). Annual 
report to the nation on the status of cancer, 1975–2002, 
featuring population-based trends in cancer treatment. 
Journal of the National Cancer Institute, 97(19), 1407-1427. 
12. Hellmann Index. (n.d.) Retrieved from http:// 
www.knmi.nl/home. 
13. Influenza activity data in EU/EEA. (n.d.). Retrieved 
from http://ecdc.europa.eu/en /healthtopics/ seasonal_ 
influenza/epidemiological_data/Pages/Latest_surveillance_
data.aspx. 
14. Nichols, L., Saunders, R., & Knollmann, F. (2012) 
Causes of Death of Patients with Lung Cancer. Archives of 
Pathology & Laboratory Medicine, 136(12), 1552-1557. 
15.  Riihimäki, M., Thomsen, H., Brandt, A., Sundquist, J., 
& Hemminki, K. (2012). Death causes in breast cancer 
patients. Annals of Oncology, 23(3), 604-610. 
16. Stolwijk, A. M., Straatman, H., & Zielhuis, G. A. (1999). 
Studying seasonality by using sine and cosine functions in 
regression analysis. Journal of Epidemiology and 
Community Health, 53(4), 235-238. 
17. Porojnicu, A. C., Lagunova, Z., Robsahm, T. E., Berg, J. 
P., Dahlback, A., & Moan, J. (2007). Changes in risk of 
death from breast cancer with season and latitude. Breast 
Cancer Research and Treatment, 102(3), 323-328. 
18. Andersen, M. H. (2014). The targeting of 
immunosuppressive mechanisms in hematological 
malignancies. Leukemia, 28(9), 1784-1792. 
19. Marín, M., Gudiol, C., Ardanuy, C., Garcia-Vidal, C., 
Jimenez, L., Domingo-Domenech, E., ... & Carratala, J. 
(2015). Factors influencing mortality in neutropenic patients 
with haematologic malignancies or solid tumours with 
bloodstream infection. Clinical Microbiology and Infection, 
21(6), 583-590.
 
 
